Evidence map›Paper›PMID 24584276›Full record

ArticleNature nanotechnology2014

Surface-stress sensors for rapid and ultrasensitive detection of active free drugs in human serum.

Joseph W Ndieyira, Natascha Kappeler, Stephen Logan, Matthew A Cooper, Chris Abell, Rachel A McKendry, Gabriel Aeppli

Abstract read
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Ultrasensitive Detection of Biomarkers in a Color-Switchable Microcavity-Reactor Laser.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Joseph W Ndieyira1] London Centre for Nanotechnology, Division of Medicine and Department of Physics and Astronomy, University College London, 17-19 Gordon Street, London WC1H 0AH, UK [2] Jomo Kenyatta University of Agriculture and Technology, Department of Chemistry, PO Box 62000, Nairobi, Kenya.
Natascha KappelerLondon Centre for Nanotechnology, Division of Medicine and Department of Physics and Astronomy, University College London, 17-19 Gordon Street, London WC1H 0AH, UK.
Stephen LoganLondon Centre for Nanotechnology, Division of Medicine and Department of Physics and Astronomy, University College London, 17-19 Gordon Street, London WC1H 0AH, UK.
Matthew A CooperInstitute for Molecular Bioscience, The University of Queensland, 306 Carmody Road, St Lucia, Brisbane 4072, Australia.
Chris AbellDepartment of Chemistry, Lensfield Road, University of Cambridge, Cambridge CB2 1EW, UK.
Rachel A McKendryLondon Centre for Nanotechnology, Division of Medicine and Department of Physics and Astronomy, University College London, 17-19 Gordon Street, London WC1H 0AH, UK.
Gabriel AeppliLondon Centre for Nanotechnology, Division of Medicine and Department of Physics and Astronomy, University College London, 17-19 Gordon Street, London WC1H 0AH, UK.
London Centre for Nanotechnology · GBJomo Kenyatta University of Agriculture and Technology · KEUniversity College London · GBUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a growing appreciation that mechanical signals can be as important as chemical and electrical signals in biology. To include such signals in a systems biology description for understanding pathobiology and developing therapies, quantitative experiments on how solution-phase and surface chemistry together produce biologically relevant mechanical signals are needed. Because of the appearance of drug-resistant hospital 'superbugs', there is currently great interest in the destruction of bacteria by bound drug-target complexes that stress bacterial cell membranes. Here, we use nanomechanical cantilevers as surface-stress sensors, together with equilibrium theory, to describe quantitatively the mechanical response of a surface receptor to different antibiotics in the presence of competing ligands in solution. The antibiotics examined are the standard, Food and Drug Administration-approved drug of last resort, vancomycin, and the yet-to-be approved oritavancin, which shows promise for controlling vancomycin-resistant infections. The work reveals variations among strong and weak competing ligands, such as proteins in human serum, that determine dosages in drug therapies. The findings further enhance our understanding of the biophysical mode of action of the antibiotics and will help develop better treatments, including choice of drugs as well as dosages, against pathogens.

Indexed as

Anti-Bacterial AgentsBacteriaBiomechanical PhenomenaBiosensing TechniquesEquipment DesignGlycopeptidesHumansLigandsLipoglycopeptidesModels, BiologicalNanotechnologySolventsSurface PropertiesVancomycinAnti-Bacterial AgentsGlycopeptidesLigandsLipoglycopeptidesoritavancinSolventsVancomycin

Identifiers

PMID24584276
OpenAlexW2079463858

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.